Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 25.10 ▼ -0.07 (-0.28%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.16% | 25.17 | 25.72 | 24.70 | 25.01 | 25.13 | 23:59:46 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 16.14 | 27.57 | 11.43 | 41.46% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,341 | 753,372 | $ 25.07 | $ 18,888,452 | 1,282,880 | 7.26 - 26.59 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:49:14 | formt | 199 | $ 25.10 | USD |
Iovance Biotherapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 3.18B | 126.19M | $ -123.58M | -1.27 | - | 105.17M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 16.70% |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 24.66 | 26.25 | 23.98 | 25.21 | 1,288,312 | 0.51 | 2.07% |
| 1 Month | 22.43 | 26.25 | 20.60 | 23.57 | 1,241,566 | 2.74 | 12.22% |
| 3 Months | 20.72 | 26.25 | 17.67 | 21.24 | 1,283,337 | 4.45 | 21.48% |
| 6 Months | 18.94 | 26.59 | 17.67 | 21.79 | 1,314,660 | 6.23 | 32.89% |
| 1 Year | 10.01 | 26.59 | 7.26 | 17.03 | 1,363,846 | 15.16 | 151.45% |
| 3 Years | 7.00 | 26.59 | 4.45 | 14.30 | 949,464 | 18.17 | 259.57% |
| 5 Years | 8.57 | 26.59 | 4.24 | 13.09 | 749,589 | 16.60 | 193.7% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc operates in the healthcare sector based in the United States. It is a pharmaceutical manufacturer attending to serious diseases such as cancer. The Company's lead pipeline candidate, LN-144, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. The TIL therapy involves growing a patient's special culture conditions outside the patient's body, or ex vivo, and then infusing the T cells back into the patient. |
